Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, according to the company’s website (see here: www.OculusIS.com). SNNLive spoke with Jim Schutz, CEO of Oculus Innovative Sciences, Inc. at Healthcare Week 2016 in San Francisco, CA.
In this video interview, Mr. Schutz and our host discuss the following topics:
- Overview of Oculus Innovative Sciences, Inc.
- Discusses the company’s products and sales
- Mr. Schutz’ background and how he got involved in Oculus
- Growth drivers for the company
- What differentiates Oculus’ products
- How the company markets its products
- Size of the scar management market
- Goals and milestones for 2016
For more information about Oculus Innovative Sciences, Inc., go to: www.OculusIS.com
The interview may contain forward looking statements about Oculus Innovative Sciences, Inc. See Oculus' periodic filings with the Securities and Exchange Commission for more complete information.
© 2017 Stock News Now
Supported by Superior Web Solutions